Amgen Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 287 Posts
1 2 3 ... 18
Healthcare (Top 30 Weights) Earnings Estimates And Revisions
Article By: T.J. Hayes Monday, February 17, 2020 5:44 AM EST
The cumulative 2020 earnings power of these 30 stocks was revised down by -.34% in the past 60 days.
In this article: EW, HCA, HUM, JNJ, LLY, MDT, MRK, PFE, SYK, TMO, UNH, ILMN, AMGN, BIIB, GILD, ISRG, VRTX Also: ABT, AGN, BAX, BDX, BMY, BSX, CI, CNC, CVS, DHR, XLV, ZTS, ABBV, ANTM
Read
Stocks Going Ex Dividend In February 2020
Article By: Fred Fuld Saturday, February 1, 2020 3:03 PM EST
The following is a short list of some of the many stocks going ex dividend during the next month. Many traders and investors use the stock trading technique called ‘Buying Dividends,’ also commonly referred to as ‘Dividend Capture.’
In this article: AEP, ED, JNJ, SLB, SO, TGT, AMGN, IBKR, NLOK
Read
Amgen Analysts Sidelined After Q4 Report, Say Valuation Reflects Growth Potential
Article By: Benzinga Friday, January 31, 2020 12:07 PM EST
Amgen, Inc.'s disappointing 2020 EPS guidance issued Thursday spooked investors, leading to a pullback in the stock.
In this article: AMGN
Read
Baird Downgrades Amgen To Underperform On Overdone 'Exuberance'
Article By: The Fly Friday, January 31, 2020 7:57 AM EST
Baird analyst Brian Skorney downgraded Amgen to Underperform from Neutral with a price target of $185, up from $173.
In this article: AMGN
Read
5 Big Drug/Biotech Stocks Set To Trump Q4 Earnings Estimates
Article By: Zacks Investment Research Wednesday, January 22, 2020 4:00 PM EST
A highlight of five big drug/biotech companies, which are expected to deliver positive earnings surprise in their upcoming quarterly earnings announcements.
In this article: AZN, MRK, ALXN, AMGN, ABBV
Read
Top Picks 2020: Amgen
Article By: MoneyShow.com Thursday, January 16, 2020 10:32 AM EST
In the third quarter of 2019, Amgen posted adjusted net income of $2.2 billion, or $3.66 per share. That topped the average analyst forecast by 13 cents.
In this article: AMGN
Read
E Market Briefing For Jan. 6, 2020
Article By: Gene Inger Monday, January 6, 2020 7:08 AM EST
The recent tensions go beyond Iran - the heart of the concern are the power-vacuum risks. But how will this affect the markets?
In this article: LIL, T, VIX, AMRN, AMGN, AMD, GM, TI, AAPL, AMZN, GOOG, FB, GOOGL, QCOM
Read
The 5 Best Biotech Stocks To Buy In 2020
Article By: Money Morning Monday, January 6, 2020 6:17 AM EST
One of the sectors with higher risk and the highest reward is biotech. Over the last 10 years, the biotech sector has produced nearly 20% annualized gains. Here are our picks for 2020.
In this article: BMY, GSK, LGND, AMGN, BIIB
Read
Amgen Pops $2.7 Bln Dose Of Risky Chinese Medicine
Article By: Lipper Alpha Insight Monday, November 4, 2019 2:11 PM EST
Amgen’s Chinese deal could be good medicine. The pharma giant is paying around $2.7 billion for a 20.5% stake in biotech group BeiGene.
In this article: AMGN Also: CELG, BGNE
Read
Week In Review: BeiGene Forms Blockbuster $2.7 Billion Collaboration With Amgen
Article By: ChinaBio® Today Sunday, November 3, 2019 1:34 AM EST
BeiGene, a Beijing cancer biopharma, announced a blockbuster collaboration with Amgen. I-Mab, a Shanghai biopharma, has filed to IPO; Aesthetic Medical International Holdings, a Shenzhen aesthetics company, completed a $30 million IPO on NASDAQ.
In this article: LLY, AMGN, BGNE, AIH, SNCA
Read
The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance
Article By: Benzinga Friday, November 1, 2019 7:38 AM EST
Here's a roundup of top developments in the biotech space over the last 24 hours.
In this article: AMGN, BGNE, MNK, PRTK, IDYA, CDNA, BLUE Also: HOTH, AGN, AZN, BMY, GSK, RMD, ACOR, ACRX, ALIM, AMAG, BCRX, CERS, IMGN, NURO, RMTI, CELG, VRTX, ABBV, AGIO, REPH, RETA, PRTO, MGNX, OPGN, MGEN, DOVA, DRNA, DCPH, TRVI, OYST, RAPT, ARDS, MIRM, ITRM, COCP, CYCN, GMAB
Read
Amgen (AMGN) Q3 Earnings And Revenues Top Estimates
Article By: Zacks Investment Research Tuesday, October 29, 2019 7:50 PM EST
Amgen came out with quarterly earnings of $3.66 per share, beating the Zacks Consensus Estimate of $3.51 per share. This compares to earnings of $3.69 per share a year ago.
In this article: AMGN
Read
3 Big Drug/Biotech Stocks Set To Beat Q3 Earnings Estimates
Article By: Zacks Investment Research Saturday, October 12, 2019 10:00 AM EST
Overall, relatively newer drugs have been driving the top line of most of the big shots backed by higher demand - a trend we expect to have benefited third-quarter sales.
In this article: LLY, ALXN, AMGN Also: JNJ
Read
Bull Of The Day: Amgen (AMGN)
Article By: Zacks Investment Research Friday, September 20, 2019 9:52 AM EST
Amgen is so far past that stage that they look attractive on a valuation basis just based on current lines of business. The potential for new best-selling drugs is just gravy for shareholders.
In this article: AMGN
Read
Wall Street's Top Stories For Monday, September 9, 2019
Article By: The Fly Monday, September 9, 2019 8:26 PM EST
Stocks had a mostly quiet trading day and finished mixed, with the Dow notching a narrow gain and the Nasdaq slipping, as AGs announce Google probe
In this article: CVET, LLY, T, ACAD, LOPE, AMGN, CYOU, GOOG, SOHU, GOOGL, PAYS
Read
Biotech (Top 30 Weights) 2019 Earnings Estimates Up 8.58% In Last 2 Months
Article By: T.J. Hayes Monday, September 9, 2019 7:36 PM EST
The cumulative earnings power of these 30 stocks was revised UP by 8.58% in the past 60 days.
In this article: ALNY, ALXN, BMRN, CBPO, ILMN, INCY, JAZZ, REGN, SGEN, AMGN, BIIB, CELG, EXEL, GILD, HZNP, MYL, NBIX, TECH, VRTX, AMRN, SAGE, GWPH, SRPT, BLUE, NVCR, IONS, BGNE, PRAH, SYNH, IBB
Read
1 to 16 of 287 Posts
1 2 3 ... 18